|
Chairman
Joshua Boger, President & CEO, Vertex Pharmaceuticals
Vice Chairman
James P. Regan, Chairman, President & CEO, Dynamics Research Corporation
President
Christopher R. Anderson, President, Mass. High Technology Council
Treasurer
Rob Scott, President & CEO, Colubris Networks
Secretary
Paul R. Gauron, Esq., Partner, Goodwin Procter LLP
Gideon Argov, CEO, Entegris, Inc.
David M. Barrett, Chairman & CEO, Lahey Clinic Hospital, Inc.
John R. Bertucci, Chairman, MKS Instruments, Inc.
Joshua Boger, President & CEO, Vertex Pharmaceuticals Incorporated
James K. Boyer, Jr., Partner, KPMG LLP
Michael A. Bradley, President & CEO, Teradyne, Inc.
Marijn Dekkers, President & CEO, Thermo Fisher Scientific
Gary DiCamillo, President & CEO, GWP International
Paul Donovan, Senior VP, Corporate Communications, Boston Scientific Corporation
Kevin Dunn, President & CEO, Canaccord Adams
Paul R.Gauron, Esq., Partner, Goodwin Procter LLP
William P. Gelnaw, Jr., Managing Partner, Choate Hall & Stewart
Paul R. Gudonis, President, FIRST
Mark Hall, President, William George Associates, Ltd.
Stephen A. Jamison, VP & General Manager, BAE Systems
Steven Kaufman, Operating Partner, Riverside Partners
David J. Laurello, President & CEO, Stratus Technologies
Martin Madaus, Chairman of the Board & CEO, Millipore Corporation
Barry Nearhos, Northeast Region Assurance Leader, PricewaterhouseCoopers
Richard Ramko, Partner, Global Biotechnology Center, Ernst & Young LLP
James P. Regan, Chairman, President, & CEO, Dynamics Research Corporation
William J. Ribaudo, Partner & Managing Director, Deloitte & Touche
Stephen H. Rusckowski, CEO, Philips Medical Systems
Rob Scott, President & CEO, Colubris Networks
James Shields, President & CEO, The Charles Stark Draper Laboratory
Ray Stata, Chairman, Analog Devices, Inc.
Patrick J. Sullivan, President & CEO, Sovereign Bank
Henri A. Termeer, Chairman, President & CEO, Genzyme Corporation
Mitch Tyson, CEO, Advanced Electron Beams
William E. Walsh, Vice President & General Manager, Lockheed Martin Sippican
David C. Weinstein, Executive Vice President, Fidelity Investments
|
